SEC Form 4 · accession 0001624073-15-000002

Syneos Health, Inc. · SYNH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Alistair Macdonald

Officer — Chief Operating Officer

Period of report

Sep 28, 2015

Accepted (ET)

Sep 29, 2015 · 4:02 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001610950

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock	Sep 28, 2015	M	44,522	$8.45	A	100,203	D
Class A Common Stock^F2	Sep 28, 2015	S	4,331	$39.708	D	95,872	D
Class A Common Stock^F3	Sep 28, 2015	S	10,510	$40.345	D	85,362	D
Class A Common Stock^F4	Sep 28, 2015	S	9,300	$40.392	D	76,062	D
Class A Common Stock^F5	Sep 28, 2015	S	5,540	$41.117	D	70,522	D
Class A Common Stock^F6	Sep 28, 2015	S	11,811	$38.841	D	58,711	D
Class A Common Stock^F7	Sep 28, 2015	S	3,030	$39.42	D	55,681	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy Class A Common Stock)^F8	$8.45	Sep 28, 2015	M	44,522	D	—	Sep 28, 2020	Class A Common Stock	44,522	103,880	D

Explanation of responses

F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2015.
F2The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.13 to $40.12, inclusive. The reporting person will provide to INC Research Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.13 to $40.78, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.76 to $40.73, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.80 to $41.44, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F6The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $38.34 to $39.33, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F7The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.35 to $39.54, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F8One half of the shares subject to this option vest yearly in five equal installments beginning on September 28, 2011, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2013, subject to continued employment.